Navigating Antipsychotic Efficacy and Metabolic Health

This chapter explores the selection of aripiprazole and its marketing strategies, alongside its side effects and efficacy in treating psychiatric symptoms. It delves into the metabolic implications of various antipsychotics, outlining the challenges of managing weight and health in psychiatric patients. The discussion includes innovative solutions like GLP-1 agonists for weight management and the careful management of medication dosages to optimize patient outcomes.